B
Britannia Life Sciences Inc
CNSX:BLAB
Britannia Life Sciences Inc
CNSX:BLAB
Price:
0.1
CAD
Market Closed
Market Cap:
CA$16.2m
Income Statement
Earnings Waterfall
Britannia Life Sciences Inc
Britannia Life Sciences Inc
Income Statement
Britannia Life Sciences Inc
Britannia Life Sciences Inc
Currency: CAD
| May-2021 | Aug-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
1
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
-71%
|
2
+118 371%
|
7
+340%
|
5
-33%
|
7
+32%
|
7
0%
|
6
-2%
|
7
+7%
|
7
+7%
|
7
+2%
|
1
-93%
|
7
+1 328%
|
7
-2%
|
7
-1%
|
4
-46%
|
2
-45%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
(3)
|
(3)
|
(3)
|
(2)
|
(1)
|
|
| Gross Profit |
0
N/A
|
0
-90%
|
1
+612 100%
|
5
+330%
|
3
-37%
|
5
+36%
|
5
+0%
|
5
+2%
|
5
+8%
|
5
+5%
|
5
0%
|
0
-97%
|
5
+3 221%
|
4
-4%
|
4
-4%
|
2
-44%
|
1
-50%
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(1)
|
(1)
|
(1)
|
(4)
|
(13)
|
(14)
|
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(2)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(4)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(1)
N/A
|
(1)
+6%
|
0
N/A
|
2
+2 225%
|
(10)
N/A
|
(10)
+5%
|
0
N/A
|
1
+642%
|
2
+55%
|
2
+2%
|
1
-21%
|
(2)
N/A
|
1
N/A
|
1
+32%
|
1
-19%
|
0
-96%
|
(1)
N/A
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(5)
|
(1)
|
0
|
(1)
|
1
|
(1)
|
(2)
|
(1)
|
0
|
(1)
|
(4)
|
(3)
|
(4)
|
(2)
|
|
| Non-Reccuring Items |
5
|
5
|
(4)
|
(10)
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
(5)
|
(5)
|
(5)
|
(5)
|
2
|
2
|
|
| Total Other Income |
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
3
N/A
|
4
+26%
|
(5)
N/A
|
(13)
-186%
|
(11)
+19%
|
(9)
+15%
|
0
N/A
|
6
+1 268%
|
2
-60%
|
2
-26%
|
2
+11%
|
(6)
N/A
|
(5)
+12%
|
(7)
-34%
|
(8)
-6%
|
(2)
+78%
|
(1)
+32%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
0
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
3
|
4
|
(5)
|
(14)
|
(11)
|
(10)
|
0
|
6
|
2
|
2
|
2
|
(6)
|
(5)
|
(7)
|
(7)
|
(2)
|
(1)
|
|
| Income to Minority Interest |
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
|
| Net Income (Common) |
3
N/A
|
4
+26%
|
(5)
N/A
|
(15)
-198%
|
(12)
+23%
|
(11)
+10%
|
(1)
+93%
|
5
N/A
|
1
-71%
|
1
-24%
|
2
+53%
|
(5)
N/A
|
(5)
-13%
|
(7)
-36%
|
(8)
-9%
|
(2)
+75%
|
(1)
+39%
|
|
| EPS (Diluted) |
0.36
N/A
|
0.13
-64%
|
-0.04
N/A
|
-0.14
-250%
|
-0.07
+50%
|
-0.06
+14%
|
0
N/A
|
0.03
N/A
|
0.01
-67%
|
0.01
N/A
|
0.01
N/A
|
-0.04
N/A
|
-0.03
+25%
|
-0.05
-67%
|
-0.05
N/A
|
-0.01
+80%
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
